This document discusses chronic obstructive pulmonary disease (COPD), including epidemiology, etiology, pathogenesis, clinical presentation, diagnosis, treatment and prognosis. It covers definitions and classifications of emphysema and chronic bronchitis. Risk factors include smoking, pollution, genetics and infections. Symptoms include dyspnea, cough and sputum production. Diagnosis involves spirometry showing airflow limitation. Treatment includes smoking cessation, medications, oxygen therapy and management of exacerbations with antibiotics and ventilation if needed. Prognosis can be assessed using indices like BODE.
Una toracostomía consiste en la introducción de un tubo en la cavidad pleural para drenar sangre, aire, bilis, pus u otro liquido, entidades que comprometen la vida de los pacientes al estar en esta localización ya que producen compresión y en casos drásticos derrames o colapsos de las estructuras del aparato respiratorio.
A través de esta presentación profundizamos un poco en indicaciones, contraindicaciones e incluso técnicas quirúrgicas.
Espero sea de su agrado esta presentación.
El derrame pleural es una acumulación patológica de materia prima en el espacio pleural. También se le conoce como pleuresía o síndrome de interposición líquida. Es una enfermedad frecuente con más de 50 causas reconocidas incluyendo enfermedades locales de la pleura, del pulmón subyacente, enfermedades sistémicas, disfunción de órganos y fármacos.
Una toracostomía consiste en la introducción de un tubo en la cavidad pleural para drenar sangre, aire, bilis, pus u otro liquido, entidades que comprometen la vida de los pacientes al estar en esta localización ya que producen compresión y en casos drásticos derrames o colapsos de las estructuras del aparato respiratorio.
A través de esta presentación profundizamos un poco en indicaciones, contraindicaciones e incluso técnicas quirúrgicas.
Espero sea de su agrado esta presentación.
El derrame pleural es una acumulación patológica de materia prima en el espacio pleural. También se le conoce como pleuresía o síndrome de interposición líquida. Es una enfermedad frecuente con más de 50 causas reconocidas incluyendo enfermedades locales de la pleura, del pulmón subyacente, enfermedades sistémicas, disfunción de órganos y fármacos.
Abstract Lung Abscess is a liquefactive necrosis of the lung tissue and arrangement of cavitation (in excess of 2 cm) containing necrotic debris and liquid brought about by parenchymal infection. It very well may be brought about by yearning, which may happen during changed cognizance and it for the most part causes a discharge filled depression. In addition, liquor addiction is the most widely recognized condition inclining to lung abscesses. Lung abscess is viewed as essential (60%) when it comes about because of existing lung parenchymal process and is named auxiliary when it entangles another procedure, e.g., vascular emboli or follows rupture of extrapulmonary abscess into lung. There are a few imaging strategies which can distinguish the material inside the thorax, for example, electronic tomography (CT) output of the thorax and ultrasound of the thorax. Broad Spectrum anti-biotics to cover blended vegetation is the pillar of treatment. Pneumonic physiotherapy and postural drainage are additionally significant. Surgeries are required in specific patients for pneumonic resection Keywords: Lung abscess, anti-bodies, video-assissted thoracoscopic medical procedure (VATS), thoracoscopy
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
Antimicrobial stewardship to prevent antimicrobial resistanceGovindRankawat1
India is among the nations with the highest burden of bacterial infections.
India is one of the largest consumers of antibiotics worldwide.
India carries one of the largest burdens of drug‑resistant pathogens worldwide.
Highest burden of multidrug‑resistant tuberculosis,
Alarmingly high resistance among Gram‑negative and Gram‑positive bacteria even to newer antimicrobials such as carbapenems.
NDM‑1 ( New Delhi Metallo Beta lactamase 1, an enzyme which inactivates majority of Beta lactam antibiotics including carbapenems) was reported in 2008
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Epoc
1.
2. INTRODUCCION
EPOC
ENFISEMA
BRONQUITIS
CRONICA
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease,Update 2014; Global initiative for Chronic Obstructive Lung Disease, available
in: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf, October 2014.
3. EPIDEMIOLOGIA
14% hombres
8% Mujeres
3er causa de mortalidad en el mundo
64 millones de personas sufren una EPOC
Available in : http://www.who.int/respiratory/copd/es/
19. EXPLORACION FISICA
Enfermedad pulmonar obstructiva crónica. GPC. Guía de PrácticaClínica, available in:
http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/037_GPC_EPOC/IMSS_037_08_EyR.pdf
20. EXPLORACION FISICA
Enfermedad pulmonar obstructiva crónica. GPC. Guía de PrácticaClínica, available in:
http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/037_GPC_EPOC/IMSS_037_08_EyR.pdf
21. EXPLORACION FISICA
Enfermedad pulmonar obstructiva crónica. GPC. Guía de PrácticaClínica, available in:
http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/037_GPC_EPOC/IMSS_037_08_EyR.pdf
22. EXPLORACION FISICA
Enfermedad pulmonar obstructiva crónica. GPC. Guía de PrácticaClínica, available in:
http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/037_GPC_EPOC/IMSS_037_08_EyR.pdf
23. CLINICA
Pred. Enfisema Pred. Bronquitis
crónica
Habito exterior Astenico Picnico
Edad >60 >50
Disnea Grave Leve
Adquisición de tos Despues de disnea Antes de disnea
Esputo Escaso, mucoso Abundante, purulento
Infecciones Poco frecuentes Mas frecuentes
PaCO2 30-40 mmHg 50-60 mmHg
PaO2 60-75 mmHg 45-60 mmHg
Poliglobulia Rara Frecuente
CTO 8va ed, Neumologia y cirugia toracica, pag 23
24. CLINICA
Pred. enfisema Pred. Bronquitis cronica
Cor pulmonale Raro, (fase terminal) frecuente
Resistencia aVia aerea Normal Aumentada
Capacidad de Difucion Disminuida Normal
Esfuerza espiratorio intenso Moderado
Auscultacion < MV Roncus y sibilancias
RxTorax • Hiperinsuflación
• Aplanamiento Diafragmatico
• Silueta Cardiaca alargada
• Bullas
• Sin patrón característico
• Aumento de trama
• Engrosamiento bronquial
• Cardiomegalia
CTO 8va ed, Neumologia y cirugia toracica, pag 23
25. Glossary ofTerms forThoracic Imaging ,Hansell et al, Fleischner Society, Radiology: Volume 246: Number 3—March 2009
26. EVALUACION Y DIAGNOSTICO
VALORAR SINTOMAS
ESPIROMETRIA
RIESGO DE EXACERBACIONES
COMORBILIDADES
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease,Update 2014; Global initiative for Chronic Obstructive Lung Disease, available
in: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf, October 2014.
27. DIAGNOSTICO: Valorar síntomas
http://www.catestonline.org
http://www.ccq.nl/
mMRC
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease,Update 2014; Global initiative for Chronic Obstructive Lung Disease, available
in: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf, October 2014.
28. DIAGNOSTICO: Valorar síntomas
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease,Update 2014; Global initiative for Chronic Obstructive Lung Disease, available
in: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf, October 2014.
29. DIAGNOSTICO: Espirometria
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease,Update 2014; Global initiative for Chronic Obstructive Lung Disease, available
in: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf, October 2014.
30. DIAGNOSTICO: Espirometria
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease,Update 2014; Global initiative for Chronic Obstructive Lung Disease, available
in: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf, October 2014.
31. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease,Update 2014; Global initiative for Chronic Obstructive Lung Disease, available
in: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf, October 2014.
32. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease,Update 2014; Global initiative for Chronic Obstructive Lung Disease, available
in: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf, October 2014.
33. DIAGNOSTICO: Pruebas adicionales
Rx tórax yTAC
Oximetría y Gasometría
Alfa 1 antitripsina
Prueba de esfuerzo
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease,Update 2014; Global initiative for Chronic Obstructive Lung Disease, available
in: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf, October 2014.
34. DIAGNOSTICO: Comorbilidades
Enf. CV
Osteoporosis
IVRAS
Depresion
DM
CA pulmon
Bronquiectasias
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease,Update 2014; Global initiative for Chronic Obstructive Lung Disease, available
in: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf, October 2014.
38. EPOC AGUDIZADA
65% bacterianas
35% virales
H. influenzae
S. pneumoniae
M. catarrhalis
¿INICIO DE ANTIBIOTICO?
CTO 8va ed, Neumologia y cirugia toracica, pag 23
40. MANEJO DE EPOC AGUDIZADA
Ventilación
mecánica
No invasiva
Ventilación
mecánica
invasiva
7.20-7.25
A pesar de
tratamiento
> <
CTO 8va ed, Neumologia y cirugia toracica, pag 26
41. PRONOSTICO: Índice de BODE
Celli, B.The body-mass index, airflow obstruction, dyspnea and exercise capcity index in chronic obstructive pulmonary disease. NEJM 2004; 350: 1005-1012.
42. Global strategy for the diagnosis, management, and prevention of chronic obstructive
pulmonary disease,Update 2014; Global initiative for Chronic Obstructive Lung Disease,
available in: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf,
October 2014.
Enfermedad pulmonar obstructiva crónica. GPC. Guía de PrácticaClínica, available in:
http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/037_GPC_EPOC/IMSS_037_08_EyR.pdf
Glossary ofTerms forThoracic Imaging ,Hansell et al, Fleischner Society, Radiology: Volum
246: Number 3—March 2009
Celli, B.The body-mass index, airflow obstruction, dyspnea and exercise capcity index
in chronic obstructive pulmonary disease. NEJM 2004; 350: 1005-1012.
CTO 8va ed, Neumologia y cirugia toracica, pag 23
Editor's Notes
Enfermedad prevenible, tratable donde hay lmitacion de airway fluid, , NO totalmente reversible y progresiva , por reaacion inflamatoria anormal ante particulas nocivs, pppalmnete TABACO
MAS ALTA EN CAUCASICOS
*Solo estos producen obstrucción clínicamente significativa **Más frecuente. *** Las manifestaciones clínicas son iguales
Centroacinar: afecta a bonquiolos respiratorios, los alveolos están respetados. Más relacionado al tabaquismo. Campos pulmonares superiores.
Panacinar: afecta alveolo y conducto alveolar y se extiende hacia bronquiolos respiratorios. Campos pulmonares inferiores.
Acinar distal: la porción distal del acino se ve afectada, es más llamativo cerca de la pleura. Relacionado a fibrosis, cicatrización o atelectasia previas.
Irregular: el acino se ve afectado de forma irregular, se asocia a cicatrices.
Principalmente hay inflamación de las VR de pequeño calibre.
Hipertrofia e hiperplasia de glándulas mucosas de VR grandes, con incremento de la producción de moco y obstrucción de las VR por moco.
Hay infiltración de linfocitos y PMN a la mucosa.
La inflamación crónica, el epitelio cilíndrico seudoestratificado ciliado normal, se reemplaza por metaplasia escamosa. La limpieza mucociliar está reducida.
Los bronquiolos están inflamados y deformados con fibrosis peribronquial.
El parénquima pulmonar permanece sin daño, mientras no coexista otra enfermedad.
La bronquitis crónica puede aparecer sin limitación del flujo de aire, pero en la EPOC siempre implica reducción del mismo.